Burosumab use in fibroblast growth factor-23-mediated hypophosphatemia in McCune-Albright syndrome/fibrous dysplasia.
Saved in:
| Title: | Burosumab use in fibroblast growth factor-23-mediated hypophosphatemia in McCune-Albright syndrome/fibrous dysplasia. |
|---|---|
| Authors: | Hasan, Marah Alsayed1 (AUTHOR), Mukaddam, Mona Al1 (AUTHOR) |
| Source: | JCEM Case Reports. Jun2026, Vol. 4 Issue 6, p1-7. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
